Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
31.99 CHF | -0.87% | +1.56% | +18.22% |
05-08 | AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents | MT |
05-08 | AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+18.22% | 15.33B | |
+21.59% | 44.15B | |
+23.03% | 23.02B | |
+12.26% | 13.74B | |
+52.55% | 12.16B | |
-10.02% | 6.84B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+12.92% | 5.66B | |
+6.11% | 4.85B |
- Stock Market
- Equities
- SDZ Stock
- News Sandoz Group AG
- Transcript : Sandoz Group AG, Q4 2023 Earnings Call, Mar 13, 2024